跳至主要内容
临床试验/EUCTR2012-002873-77-NL
EUCTR2012-002873-77-NL进行中(未招募)不适用

The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndrome - Intranasal insulin in PMS

niversity Medical Center Groningen, Department of Genetics0 个研究点开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age between 12 months and 18 years 0 months old at 1-1-2013
  • Proven SHANK3 deletion by array-comparative genomic hybridization (array-CGH)
  • Parents need to speak and understand Dutch
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 20
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A contra-indication for the use of intranasal application (e.g. anatomical obstruction)
  • Severe perinatal brain damage (e.g. asphyxia, haemorrhage, infection)
  • A metabolic or muscle disease responsible for neurological symptoms, independent of the 22q13 deletion

研究者

发起方
niversity Medical Center Groningen, Department of Genetics

相似试验

The effect of insulin nasal spray on development and... | 临床试验